U.S. flag

An official website of the United States government

NM_005055.5(RAPSN):c.264C>A (p.Asn88Lys) AND Congenital myasthenic syndrome 4C

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jan 17, 2014
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000008512.18

Allele description [Variation Report for NM_005055.5(RAPSN):c.264C>A (p.Asn88Lys)]

NM_005055.5(RAPSN):c.264C>A (p.Asn88Lys)

Gene:
RAPSN:receptor associated protein of the synapse [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p11.2
Genomic location:
Preferred name:
NM_005055.5(RAPSN):c.264C>A (p.Asn88Lys)
Other names:
p.N88K
HGVS:
  • NC_000011.10:g.47448079G>T
  • NG_008312.1:g.6100C>A
  • NM_005055.5:c.264C>AMANE SELECT
  • NM_032645.5:c.264C>A
  • NP_005046.2:p.Asn88Lys
  • NP_005046.2:p.Asn88Lys
  • NP_116034.2:p.Asn88Lys
  • NC_000011.9:g.47469631G>T
  • NM_005055.3:c.264C>A
  • NM_032645.4:c.264C>A
  • Q13702:p.Asn88Lys
Protein change:
N88K; ASN88LYS
Links:
UniProtKB: Q13702#VAR_021217; OMIM: 601592.0001; dbSNP: rs104894299
NCBI 1000 Genomes Browser:
rs104894299
Molecular consequence:
  • NM_005055.5:c.264C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_032645.5:c.264C>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Congenital myasthenic syndrome 4C (CMS4C)
Synonyms:
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency; Myasthenic syndrome, congenital, postsynaptic, associated with acetylcholine receptor deficiency
Identifiers:
MONDO: MONDO:0012157; MedGen: C1837091; Orphanet: 590; OMIM: 608931

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000221210Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine - CSER-MedSeq
criteria provided, single submitter

(LMM Criteria)
Pathogenic
(Jan 17, 2014)
germlineclinical testing

PubMed (14)
[See all records that cite these PMIDs]

SCV001163637Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.

Yasaki E, Prioleau C, Barbier J, Richard P, Andreux F, Leroy JP, Dartevelle P, Koenig J, Molgó J, Fardeau M, Eymard B, Hantaï D.

Neuromuscul Disord. 2004 Jan;14(1):24-32.

PubMed [citation]
PMID:
14659409

Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.

Cossins J, Burke G, Maxwell S, Spearman H, Man S, Kuks J, Vincent A, Palace J, Fuhrer C, Beeson D.

Brain. 2006 Oct;129(Pt 10):2773-83. Epub 2006 Aug 31.

PubMed [citation]
PMID:
16945936
See all PubMed Citations (15)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine - CSER-MedSeq, SCV000221210.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (14)

Description

The Asn88Lys variant in RAPSN has been previously identified in many individuals with congenital myasthenic syndrome and has been shown to segregate with disease in several affected family members (Ohno 2002, Dunne 2003, Richard 2003, Muller 2003, Banwell 2004, Yasaki 2004, Muller 2004, Ioos 2004, Cossins 2006, Skeie 2006, Milone 2009, Brugoni 2010, Bell 2011, Alseth 2011). This variant has been identified in 0.01% (13/8596) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs104894299). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Functional studies indicate the Asn88Lys variant results in reduced co-localization with the acetylcholine receptor (AChR) (Cossins 2006). In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM) based upon segregation studies and functional evidence.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

From Baylor Genetics, SCV001163637.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024